Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Asthma treatment: inhaled beta-agonists

M R Sears1

  • 1St Joseph's Hospital and McMaster University, Hamilton, Canada. searsm@fhs.csu.mcmaster.ca

Canadian Respiratory Journal
|September 30, 1998
PubMed
Summary

Short-acting beta-agonists offer quick asthma symptom relief but regular use is discouraged due to risks. Long-acting beta-agonists, when combined with inhaled corticosteroids, improve asthma control and reduce exacerbations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The influence of maternal and infant nutrition on cardiometabolic traits: novel findings and future research directions from four Canadian birth cohort studies.

The Proceedings of the Nutrition Society·2019
Same author

Impact of maternal pre-pregnancy overweight on infant overweight at 1 year of age: associations and sex-specific differences.

Pediatric obesity·2018
Same author

Human milk oligosaccharide profiles and food sensitization among infants in the CHILD Study.

Allergy·2018
Same author

Patterns of allergic sensitization and atopic dermatitis from 1 to 3 years: Effects on allergic diseases.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017
Same author

Adiponectin, leptin and insulin in breast milk: associations with maternal characteristics and infant body composition in the first year of life.

International journal of obesity (2005)·2017
Same author

Infant gut immunity: a preliminary study of IgA associations with breastfeeding.

Journal of developmental origins of health and disease·2015

Area of Science:

  • Pulmonology
  • Pharmacology
  • Allergy and Immunology

Background:

  • Short-acting beta-agonists (SABAs) are widely used for rapid asthma symptom relief.
  • However, their regular use for chronic asthma maintenance is no longer recommended due to potential risks.
  • Excessive SABA use is linked to increased airway hyper-responsiveness and a higher risk of severe asthma exacerbations.

Purpose of the Study:

  • To evaluate the role of short-acting and long-acting beta-agonists in asthma management.
  • To assess the safety and efficacy of long-acting beta-agonists (LABAs) in combination with inhaled corticosteroids (ICS).
  • To investigate the impact of LABAs on asthma exacerbation rates.

Main Methods:

  • Review of existing literature and clinical studies on beta-agonist therapy in asthma.
  • Analysis of data comparing SABA use with LABA use, including combination therapy with ICS.
  • Examination of studies assessing airway hyper-responsiveness and exacerbation rates.

Main Results:

  • SABAs provide rapid bronchodilation but frequent use is associated with decreased asthma control and increased risk of severe events.
  • LABAs (salmeterol, formoterol) offer prolonged bronchodilation and symptom reduction.
  • Combination therapy of LABAs with ICS, particularly budesonide/formoterol, significantly reduced asthma exacerbation rates compared to low-dose ICS alone.

Conclusions:

  • SABAs should be used only as needed for infrequent symptom relief.
  • LABAs are indicated as an add-on therapy for asthma not controlled by moderate-dose ICS.
  • LABAs are complementary to ICS and not a substitute, with combination therapy demonstrating improved asthma control and reduced exacerbations.

Related Experiment Videos